RxDoctor Payments Data

Celeste Hicken

Family · Midvale, UTNPI 1700351830

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $82,365 of the $104,816 with a category attached, or 78.6%. AbbVie accounts for 99.4% of it on its own, with 2 other manufacturers making up the rest. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$104,816in general payments, 2019–2025

Across 296 payments — averaging $354.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$104K
  • Galderma Laboratories, L.p.$358
  • Merz North America, Inc.$255

What the payments were for

  • Consulting fees$5000%
  • Speaking & faculty fees$82,36579%
  • Travel & lodging$15,03814%
  • Food & beverage$6,8877%
  • Education$250%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)286$104,202
Galderma Laboratories, L.p.5$358
Merz North America, Inc.5$255

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$104,816 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Other family in Midvale

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →